TrialBritish journal of cancer2008

A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.

A L Farquharson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.